Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Unterrainer

Showing results (401-410 of 459) with videos related to

Pageof 46
Sort By:
Frontiers in Neurology|July 6, 2018
Clinical Routine FDG-PET Imaging of Suspected Progressive Supranuclear Palsy and Corticobasal Degeneration: A Gatekeeper for Subsequent Tau-PET Imaging?Leonie Beyer, Johanna Meyer-Wilmes, Sonja Schönecker, et al.
Suicide & Life-Threatening Behavior|September 4, 2019
Suicide and Personality Traits: A Multicenter Study of Austrian and Italian Psychiatric Patients and StudentsStefan Stefa-Missagli, Human-Friedrich Unterrainer, Giancarlo Giupponi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 26, 2025
Early changes of PSMA PET expression after initiation of androgen receptor signaling inhibitors in CRPC: an international multicenter retrospective studyLena M Unterrainer, Andrea Farolfi, Tristan Grogan, et al.
Frontiers in Oncology|June 7, 2021
Feasibility of Different Tumor Delineation Approaches for <sup>18</sup>F-PSMA-1007 PET/CT Imaging in Prostate Cancer PatientsLena M Mittlmeier, Matthias Brendel, Leonie Beyer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 24, 2018
Comparison of <sup>18</sup>F-GE-180 and dynamic <sup>18</sup>F-FET PET in high grade glioma: a double-tracer pilot studyMarcus Unterrainer, D F Fleischmann, C Diekmann, et al.
Neuroimage. Clinical|August 10, 2019
Neuronal injury biomarkers for assessment of the individual cognitive reserve in clinically suspected Alzheimer's diseaseLeonie Beyer, Jonas Schnabel, Philipp Kazmierczak, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 12, 2026
PSMA PET/CT-Derived Indicators and Outcomes After [<sup>177</sup>Lu]Lu-PSMA-617: A Multicenter Retrospective Analysis from the U.S. Expanded-Access ProgramKoichiro Kimura, Vishnu Murthy, Andrew F Voter, et al.
Clinical & Experimental Metastasis|February 29, 2024
Differentiation of benign and metastatic lymph nodes in soft tissue sarcomaAnton Burkhard-Meier, Vindi Jurinovic, Luc M Berclaz, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 28, 2021
<sup>68</sup>Ga-EMP-100 PET/CT-a novel ligand for visualizing c-MET expression in metastatic renal cell carcinoma-first in-human biodistribution and imaging resultsLena M Mittlmeier, Andrei Todica, Franz-Josef Gildehaus, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 12, 2026
Phase 2 Prospective Trial of Retreatment with [<sup>177</sup>Lu]Lu-PSMA-617 Molecular Radiotherapy for Metastatic Castration-Resistant Prostate Cancer-RE-LuPSMAJohn Nikitas, Adrien Holzgreve, Jesus Juarez, et al.
Pageof 46

Showing results (401-410 of 459) with videos related to

Sort By:
Pageof 46
Frontiers in Neurology|July 6, 2018
Clinical Routine FDG-PET Imaging of Suspected Progressive Supranuclear Palsy and Corticobasal Degeneration: A Gatekeeper for Subsequent Tau-PET Imaging?Leonie Beyer, Johanna Meyer-Wilmes, Sonja Schönecker, et al.
Suicide & Life-Threatening Behavior|September 4, 2019
Suicide and Personality Traits: A Multicenter Study of Austrian and Italian Psychiatric Patients and StudentsStefan Stefa-Missagli, Human-Friedrich Unterrainer, Giancarlo Giupponi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 26, 2025
Early changes of PSMA PET expression after initiation of androgen receptor signaling inhibitors in CRPC: an international multicenter retrospective studyLena M Unterrainer, Andrea Farolfi, Tristan Grogan, et al.
Frontiers in Oncology|June 7, 2021
Feasibility of Different Tumor Delineation Approaches for <sup>18</sup>F-PSMA-1007 PET/CT Imaging in Prostate Cancer PatientsLena M Mittlmeier, Matthias Brendel, Leonie Beyer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 24, 2018
Comparison of <sup>18</sup>F-GE-180 and dynamic <sup>18</sup>F-FET PET in high grade glioma: a double-tracer pilot studyMarcus Unterrainer, D F Fleischmann, C Diekmann, et al.
Neuroimage. Clinical|August 10, 2019
Neuronal injury biomarkers for assessment of the individual cognitive reserve in clinically suspected Alzheimer's diseaseLeonie Beyer, Jonas Schnabel, Philipp Kazmierczak, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 12, 2026
PSMA PET/CT-Derived Indicators and Outcomes After [<sup>177</sup>Lu]Lu-PSMA-617: A Multicenter Retrospective Analysis from the U.S. Expanded-Access ProgramKoichiro Kimura, Vishnu Murthy, Andrew F Voter, et al.
Clinical & Experimental Metastasis|February 29, 2024
Differentiation of benign and metastatic lymph nodes in soft tissue sarcomaAnton Burkhard-Meier, Vindi Jurinovic, Luc M Berclaz, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 28, 2021
<sup>68</sup>Ga-EMP-100 PET/CT-a novel ligand for visualizing c-MET expression in metastatic renal cell carcinoma-first in-human biodistribution and imaging resultsLena M Mittlmeier, Andrei Todica, Franz-Josef Gildehaus, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 12, 2026
Phase 2 Prospective Trial of Retreatment with [<sup>177</sup>Lu]Lu-PSMA-617 Molecular Radiotherapy for Metastatic Castration-Resistant Prostate Cancer-RE-LuPSMAJohn Nikitas, Adrien Holzgreve, Jesus Juarez, et al.
Pageof 46